首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pneumonia

缩写:

ISSN:2200-6133

e-ISSN:2200-6133

IF/分区:6.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引226
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jan Mizera,Samuel Genzor,Milan Sova et al. Jan Mizera et al.
Rationale: Persistent respiratory symptoms following Coronavirus Disease 2019 (COVID-19) are associated with residual radiological changes in lung parenchyma, with a risk of development into lung fibrosis, and with impair...
Maha E Houssen,Marwa O Elmaria,Dina Badr et al. Maha E Houssen et al.
Toll-like receptor 4 (TLR4) signaling mediates sustained systemic inflammation in(COVID)-19 patients. We aimed to assess the serum levels of sTLR4 and sCD14 as negative regulators of Toll like receptor signaling and their association with l...
Lucía Boix-Palop,María J Arranz,Anna Sangil et al. Lucía Boix-Palop et al.
Background: Pneumococcal community-acquired pneumonia (P-CAP) is a major cause of morbidity and hospitalization. Several host genetics factors influencing risk of pneumococcal disease have been identified, with less infor...
Maru Zewdu Kassie,Molalign Gualu Gobena,Yihenew Mitiku Alemu et al. Maru Zewdu Kassie et al.
Background: The Novel Coronavirus disease (COVID-19) pandemic has become a global threat. Determining the time to recovery from COVID-19 is intended to assist healthcare professionals in providing better care, and plannin...
Taiga Miyazaki,Kiyoyasu Fukushima,Kohji Hashiguchi et al. Taiga Miyazaki et al.
Background: Current microbiological tests fail to identify the causative microorganism in more than half of all pneumonia cases. We explored biomarkers that could be used for differentiating between bacterial and viral pn...
Katia J Bruxvoort,Heidi Fischer,Joseph A Lewnard et al. Katia J Bruxvoort et al.
Background: Respiratory pathogens, including SARS-CoV-2, can cause pulmonary structural damage and physiologic impairment, which may increase the risk of subsequent lower respiratory tract infections (LRTI). Prior hospita...
Zirui Wang,Cong Wang,Xiaohua Fei et al. Zirui Wang et al.
Introduction: Thymosin drugs are commonly used for the treatment of viral infections due to their immunomodulatory effects. The comprehensive clinical efficacy of Thymalfasin therapy for COVID-19 associated pneumonia is n...
C Joris Yzermans,Youri P Moleman,Peter Spreeuwenberg et al. C Joris Yzermans et al.
Background: Although the association between living in the vicinity of a goat farm and the occurrence of pneumonia is well-documented, it is unclear whether the higher risk of pneumonia in livestock dense areas is season-...
Alex J J Lister,Evelin Dombay,David W Cleary et al. Alex J J Lister et al.
Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital fo...
Phuong Tk Nguyen,Tam Tm Nguyen,Lan Tb Huynh et al. Phuong Tk Nguyen et al.
Objective: To assess the safety and utility of a pragmatic clinical algorithm to guide rational antibiotic use in children presenting with respiratory infection. ...